The Latest Breaking News from KVUE

Unusually Active: 4 Options to Watch Next Month for Potential Future Gains

Overall options volume was about average on Thursday, with calls accounting for 60% of the action. Of the 1,291 unusually active options on the day, here are four to watch in the next month.

Barchart · Oct 24, 2025

Kenvue's Quarterly Earnings Preview: What You Need to Know

Kenvue is expected to announce its third-quarter results by early November, and analysts expect a notable decline in earnings.

Barchart · Oct 23, 2025

Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.

The former consumer health unit of Johnson & Johnson remains mired in troubles surrounding Tylenol.

Barchart · Oct 22, 2025

Quadruple murder at Austin yogurt shop was one of city’s most infamous cold cases. 30 years later police have a suspect

Serial killer Robert Eugene Brashers, who died by suicide in 1999, committed at least seven murders across multiple states between 1990 and 1998, prior to the Austin yogurt shop killings

The Independent UK · Sep 30, 2025

As Trump Takes Aim at Tylenol, Should You Buy, Sell, or Hold Parent Company Kenvue Stock’s Here?

Kenvue stock is trailing the broader markets by a wide margin in 2025 due to regulatory concerns over its flagship Tylenol product.

Barchart · Sep 24, 2025

Kenvue Surges Over 2% Pre-Market Despite Trump Administration's Autism Warning

Kenvue Inc. (NYSE:KVUE) saw its stock rise by 2.61% to $17.69 in pre-market trading on Wednesday, despite concerns stirred by President Trump's controversial comments about acetaminophen potentially being linked to autism.

Benzinga · Sep 24, 2025

What's Going On With Kenvue Stock Tuesday?

Kenvue Inc. (NYSE:KVUE) shares are trading higher Tuesday despite President Donald Trump saying the Food and Drug Administration will notify physicians that use of acetaminophen or Tylenol during pregnancy could be associated with increase risk of autism.

Benzinga · Sep 23, 2025

Jim Cramer Says Trump Is Creating 'A Nightmare' For Kenvue As President Links Tylenol With Autism

CNBC’s Jim Cramer warned Tuesday that President Donald Trump is creating a “nightmare of potential litigation” for consumer health giant Kenvue Inc. (NYSE:KVUE), sending the company's stock tumbling.

Benzinga · Sep 23, 2025

Nvidia, Kenvue, Rivian, MicroCloud Hologram And Opendoor: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks closed higher on Monday, with the Dow Jones Industrial Average edging up 0.14% to 46,381.54. The SP 500 added 0.4% to finish at 6,693.75, while the Nasdaq climbed 0.7% to 22,788.98.These are the top stocks that gained the attention of retail traders and investors through the day: Nvidia…

Benzinga · Sep 23, 2025

Kenvue Stock Is Sliding Today: What's Fueling The Sell-Off?

Shares of Kenvue Inc (NASDAQ:KVUE) are down Monday in anticipation of a negative Trump administration announcement about one of its products.

Benzinga · Sep 22, 2025